U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07415031) titled 'A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies' on Feb. 11.
Brief Summary: This is an open-label, solid tumor, continuation, rollover trial which enrolls participants from ongoing BMS parent studies that evaluated adagrasib (MRTX849, BMS-986503) either as monotherapy or in combination with other cancer therapies in patients with non-small cell lung cancer (NSCLC), colorectal cancer (CRC) and other advanced solid tumors.
Study Start Date: May 16, 2026
Study Type: INTERVENTIONAL
Condition:
Solid Tumors
Intervention:
DRUG: Adagrasib
Specified dose on specified days
DRUG: Pem...